{"name":"China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.","slug":"china-resources-sanjiu-medical-pharmaceutical-co-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":3,"colorKey":"oncology","drugs":[{"name":"Jinfukang oral liquid","genericName":"Jinfukang oral liquid","slug":"jinfukang-oral-liquid","indication":"Other","status":"marketed"},{"name":"Shenfu Zhusheye","genericName":"Shenfu Zhusheye","slug":"shenfu-zhusheye","indication":"Other","status":"marketed"},{"name":"Yuxuebi tablet","genericName":"Yuxuebi tablet","slug":"yuxuebi-tablet","indication":"Other","status":"marketed"}]}],"pipeline":[{"name":"Jinfukang oral liquid","genericName":"Jinfukang oral liquid","slug":"jinfukang-oral-liquid","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Shenfu Zhusheye","genericName":"Shenfu Zhusheye","slug":"shenfu-zhusheye","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Yuxuebi tablet","genericName":"Yuxuebi tablet","slug":"yuxuebi-tablet","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.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?oc=5","date":"2026-04-03","type":"earnings","source":"simplywall.st","summary":"3 Asian Growth Stocks With High Insider Ownership Growing Earnings Up To 64% - simplywall.st","headline":"3 Asian Growth Stocks With High Insider Ownership Growing Earnings Up To 64%","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxON08tai16VElsdm9VMy1jemV4Z3ZhZ1ZzUHlBN0w2NzlwX1pNTEg4bFpBaW9wbldSMHo1RV90MHgyRlBoTEx2bVNldkhobzc1TXJiODM0MHN6cHdYaTFJbXlnT05kRUEzT2ZMbmt0S3BtV3RRYW00VXZJQUZuQXNjY3dFTHE5RkV4LTJpSjZyRFdTREpGMnVUX1RGT3pUaFNoc2VYWm5fYlFvQTU1akFNMzZ3?oc=5","date":"2026-03-24","type":"earnings","source":"富途牛牛","summary":"China Resources Pharmaceutical (03320) released its annual results, with a net profit attributable to shareholders of 4.045 billion yuan, representing a year-on-year increase of 20.73%. Both revenue a","headline":"China Resources Pharmaceutical (03320) released its annual results, with a net profit attributable to shareholders of 4.","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihgFBVV95cUxNYktIV2VIa2V0em5UMzdmUFRYQUpGaXVXYkRLSWJMXzE2THhnY3VuTlppemRRUENnT3g4MXVPNEtDZ2lVRjFiVDBOeTZFajJGVUFSUlJwRTNZWkpFSmdiQUR1MlRQQ2pxZU1ZcjFESDU5TjNjNjJLNmxEa1FpRFhUM1ZBNzdvQQ?oc=5","date":"2025-09-15","type":"deal","source":"JD Supra","summary":"Merger Control in China’s Healthcare Industry: Insights into Antitrust Review and Market Trends - JD Supra","headline":"Merger Control in China’s Healthcare Industry: Insights into Antitrust Review and Market Trends","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiekFVX3lxTE9JUG5ZTlkxVFlFeTlIQkxwVWliZmZmRHZoajIyVGp0LS1QWTFJX2tPNjRVUFE4ZGxSaWhwNmJVUFN1UHFZQVYzaWJkaWN6dDdTSWJVakdWZmoycUNNbU9TYXoyeE5VOUZHY3hkV2UwZG1GM2owYnpMcndR?oc=5","date":"2025-09-03","type":"pipeline","source":"Growth Dragons","summary":"China Resources: From Snow Beer to Microchips - How One Company Touches Every Part of Life in China - Growth Dragons","headline":"China Resources: From Snow Beer to Microchips - How One Company Touches Every Part of Life in China","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxOWlVObG04V1hDdV9wemR1RnJoN1ZNX2o4MDU4V3NJSV9BZjhnOVdKWXRNQ3cyNVVRdU1ReVhmSjkyMVFrbHlHOUFXZjY0am8zVzh6ZHAxVHpiTUYzMXd1eDE0bXd6NTJ2ajlmaHRia29tLVd0R2pHd0g3azZtTWVFLTZVclhRVlJ6SkI3NE1BUkRIZXFoa1hFLXJHVk5UbWRmc0hZXzVWX0JTRV9uY1BPM1VxZHREbDBQZFd1WQ?oc=5","date":"2024-08-05","type":"pipeline","source":"Yicai Global","summary":"TCM Giant China Resources Sanjiu to Take Control of Peer for USD869 Million - Yicai Global","headline":"TCM Giant China Resources Sanjiu to Take Control of Peer for USD869 Million","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiywFBVV95cUxNTk96dUM4RERqWVN1VzFrdnVPVWFaTUhDSC1sck15WnpQOUJHcWJpNkhQeW5YWEFFNE0yTTRmazVoRHQ4NkpfRlpnZThHY0U4cTU0ZnhLWEJfV0RUNmhENDJXWUZpUlBJdmtRb2NUWjNYV3BPaDJrYTlqWU1mXzl2UERvd3JiQnNsekQxNVg5bnN0QXBrU3ltMEt4SUwtTlpadUhlZEJIa01pNlRISnVmZGZvQ1JmYlZwMGdGbXh5ZHJSeFNtcmxvcW80cw?oc=5","date":"2022-12-15","type":"pipeline","source":"Reuters","summary":"China urges companies to ensure COVID-related medical supplies - Reuters","headline":"China urges companies to ensure COVID-related medical supplies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxQVF93cjhlbTk0TWFFU1lzX3RQX1dlZFM4Slp3S2pDZjc2WW9IR2xjVnltaEFadGxKUTlGWUF4aDlaTkphdWJBQmgyVG5MU2JHaVJXQXNzV3pZbWpoX1Zyby1FSGRLb2dtRWRrcUFLSTQwQ2ZMTFZnYkxyb2FwcnlPU0VRdlI1eFhKZlhmbGVOSTQydnBLUXd1SEdUSHFKdFZ5UUlIRmM4Y1BiN3VPNjExSzhrdzZqdw?oc=5","date":"2022-05-09","type":"deal","source":"Yicai Global","summary":"Kpc Surges After China Resources Sanjiu Buys 28% Stake in Chinese Ginseng Retailer - Yicai Global","headline":"Kpc Surges After China Resources Sanjiu Buys 28% Stake in Chinese Ginseng Retailer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxOaUxhR0MyREJLdTBxNmhTMTB4ekpXS3JEazV2Q2JpRmlfLU81UjU4bjNwUmN3OEZtRUtFT0NkNlRLNUdadDJHV1FTeGFqNFdZLXdiUVNkNk9zWDU2TFRmZ3FOblNtOXNBcS1DMzB3LWJrM3MtMG9BX3Z1RmZaSmdJdGhrb0gxaEIxRHE0dDVn?oc=5","date":"2020-12-01","type":"pipeline","source":"Quiver Quantitative","summary":"Dimensional Emerging Core Equity Market ETF Holdings - Quiver Quantitative","headline":"Dimensional Emerging Core Equity Market ETF Holdings","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiXEFVX3lxTE83cVZhbk9JRGFCVHN6NmoySWxpRWh6UmNKRXFPazRNT0dKNFQ5N2l0M19GTnlPOEFhWmJmdnNHMzZfMXF1M0RvN2ZqVnlYa0JVX05CNHd5dlZGc1k5?oc=5","date":"2017-12-30","type":"pipeline","source":"TradingView","summary":"000999 Stock Price and Chart — SZSE:000999 - TradingView","headline":"000999 Stock Price and Chart — SZSE:000999","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiWEFVX3lxTE4tSFE1TGhYcFhMS2RfMFZGOFJnbk8yQlpISnMwd1hOanljNVBHTk5reVNOcVVnb09lOFFqc3RIc3U2dHdxWEgxeUZRUGNEWE9ZQUVsMHpJRTU?oc=5","date":"2017-06-12","type":"pipeline","source":"Yahoo Finance Singapore","summary":"Huadong Medicine Co., Ltd (000963.SZ) stock price, news, quote and history - Yahoo Finance Singapore","headline":"Huadong Medicine Co., Ltd (000963.SZ) stock price, news, quote and history","sentiment":"neutral"}],"patents":[],"drugCount":3,"phaseCounts":{"marketed":3},"enrichmentLevel":0,"visitCount":4,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}